NCT03458884

Brief Summary

Post-stroke fatigue is common and negatively influences post-stroke recovery. Today, there is insufficient evidence how to treatment post-stroke fatigue. Our objective is to investigate if a structured cardiorespiratory interval training program added to the early supported discharge (ESD)-service results in relieved post-stroke fatigue and increased oxygen uptake. This is a 1:1 prospective randomized open- label trial(Two-centre study) with blinded evaluators (PROBE-design) of 50 participants referred to ESD with study start at 4 (±1) weeks after discharge from the stroke unit. The intervention group (N=25) receives a structured cardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks. The cardiorespiratory interval training program comprises of 4x4 minute interval, at 70 to 80% of peak heart rate, interrupted by 3 minutes active recovery. The control group (N=25) receives usual ESD care. The primary outcome will be a shift in the Swedish Fatigue Assessment Scale before intervention (baseline) versus 8 weeks months after start of intervention in the intervention and control groups. Secondary outcomes include cardiorespiratory fitness, compliance, adherence and adverse events.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

March 19, 2018

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

6.7 years

First QC Date

March 2, 2018

Last Update Submit

May 10, 2024

Conditions

Keywords

StrokeFatiguePROBE designCardiorespiratory fitnessCardiorespiratory training

Outcome Measures

Primary Outcomes (1)

  • Post-stroke fatigue

    Post-stroke fatigue will be measured with The Swedish Fatigue Assessment Scale (S-FAS) comprises 10 questions that describe how a person generally feels. The answers are given using a 5-point scale ranging from 1 (never) to 5 (always) such that the total score ranges from 10 to 50 points. Items 4 and 10 require reversed scoring. A high score indicate an increase level of fatigue.

    The S-FAS will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)

Secondary Outcomes (4)

  • Cardiorespiratory fitness (Peak oxygen consumption, VO2peak)

    Cardiorespiratory fitness (peak oxygen consumption) will be measured before intervention (pre-treatment test) and immediately after end of 8 week intervention (post-treatment test)

  • Feasibility (Fidelity)

    Fidelity will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks

  • Feasibility (Adherence)

    Adherence will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks

  • Feasibility (Adverse events)

    Adverse events will be measured throughout the intervention and will be monitored at each individual training session, 3 days a week for 8 weeks

Study Arms (2)

Cardiorespiratory interval training

EXPERIMENTAL

Cardiorespiratory interval training program on ergometer cycle, 30-40 minutes, 3 days a week for 8 weeks.

Other: Cardiorespiratory interval training

Usual care

NO INTERVENTION

Usual ESD care including information about post-stroke fatigue, support and practical advice about how to identify and manage fatigue symptoms in daily tasks, such as the adaptation and prioritization of activities, physical activity and rest.

Interventions

A structured cardiorespiratory interval training program on an ergometer cycle 3 days a week for 8 weeks.

Cardiorespiratory interval training

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Preliminary or final diagnosis of acute stroke due to Brain infarction: large vessel disease, lacunar syndrome, cryptogenic stroke Intracerebral hemorrhage
  • Post-stroke fatigue (defined as a summation score of 28 or more on the S-FAS)
  • Medical stability
  • Independent living in Umeå or Gävle (in the nearby surrounding areas) and able to cycle an ergometer cycle.

You may not qualify if:

  • Patients with severe stroke with modified Rankin Scale \>3
  • Atrial fibrillation, pacemaker or other arrhythmia which exclude reliable monitoring of heart-frequency
  • Unstable pulmonary or cardiac disease
  • Serious co-morbidity with for example terminal cancer, hemodialysis, severe cognitive dysfunction with Montreal Cognitive Assessment (MOCA) ≤ 26
  • Drug abuse
  • Patients living far away from the hospital or in residential care facilities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anna Bråndal

Umeå, s-90185, Sweden

RECRUITING

MeSH Terms

Conditions

StrokeFatigue

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anna Bråndal, PhD

    Department of Community Medicine and Rehabilitation, Physotherapy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anna Bråndal, PhD

CONTACT

Per Wester, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 1:1 prospective randomized open-label trial with blinded evaluators (PROBE-design)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

March 2, 2018

First Posted

March 8, 2018

Study Start

March 19, 2018

Primary Completion

December 1, 2024

Study Completion

March 1, 2025

Last Updated

May 13, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations